Mass Torts Update - Written by Beasley Allen on Tuesday, August 7, 2012 14:29 - 0 Comments

An Update On Plavix Litigation

Sanofi-Aventis and Bristol-Myer Squibb, the manufacturers of , have received several FDA warning letters regarding false and misleading statements made in promotional materials for the blood thinner. These FDA letters clearly indicate that the manufacturers were more concerned with increasing sales and profits, at the expense of providing fair and accurate information to consumers and doctors. At the time was developed, the makers’ own studies demonstrated that the drug was not any better than Aspirin at preventing heart attacks and strokes.

Through proper evaluation of clinical trials, the limited benefits as opposed to the increased risk of heart attacks, strokes, internal bleeding and even death should have been apparent. There has been a great deal of around the country. The FDA asked the manufacturers on several occasions to change their misleading statements and stop promoting unproven uses of the medication. But nothing was done. Finally, the new warning has a black box, the FDA’s most severe warning.

Anyone who has taken and suffered a heart attack or had a family member who died after taking the drug can contact Melissa Prickett, a in our Mass Torts Section, to find out if there is a potential claim. Melissa can be contacted at 800-898-2034 or by email at Melissa.Prickett@beasleyallen.com.



Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Recent Settlements - Feb 9, 2012 7:09 - 0 Comments

Settlement In BTSI Defect Case

More In Recent Settlements


Product Liability - Jul 7, 2014 13:19 - 0 Comments

Petition Seeks To Block CarMax Sales Of Unrepaired Recalled Cars

More In Product Liability


Recalls Update - Jul 7, 2014 9:13 - 0 Comments

250,000 Glass Knobs Sold By World Market Recalled Due To Cutting Risk

More In Recalls Update